Bryan Roberts joined Venrock in 2000 immediately after earning a PhD in Chemistry & Chemical Biology from Harvard, following an undergraduate degree at Dartmouth, bringing genuine scientific depth to healthcare investing. He became a driving force in restructuring Venrock starting in 2007, helping winnow the firm's partner ranks and later establishing an equal-carry compensation structure across all partners regardless of who sourced a given deal - a structural choice meant to incentivize collective success over individual credit. Roberts has anchored Venrock's healthcare practice for more than two decades, backing companies including athenahealth, Illumina, Castlight Health, and Grand Rounds, and remains one of the firm's most senior and long-tenured healthcare investors.
Education
BA, Dartmouth College
PhD, Chemistry & Chemical Biology, Harvard University